AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
Clinical trial NCT05602363 · RECRUITING
Trial details
- NCT number
- NCT05602363
- Sponsor
- Carna Biosciences, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-01
- Primary completion
- 2027-09-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.